{"slideshow_credits": null, "snippet": "Mr. Shkreli\u2019s new defense lawyer, Benjamin Brafman, said he had advised his client, who faces securities fraud charges, to stop talking to the media and posting on Twitter.", "abstract": "Martin Shkreli, according to his defense lawyer Benjamin Brafman, has been advised to keep low profile in court, on social media and with news media; Brafman says his client will assert his Fifth Amendment rights during scheduled testimony before House Committee on Oversight and Government Reform.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Matthew", "role": "reported", "lastname": "GOLDSTEIN", "rank": 1, "organization": ""}, {"firstname": "Alexandra", "role": "reported", "lastname": "STEVENSON", "rank": 2, "organization": ""}], "original": "By MATTHEW GOLDSTEIN and ALEXANDRA STEVENSON"}, "web_url": "http://www.nytimes.com/2016/02/04/business/martin-shkreli-appears-to-adopt-a-new-legal-strategy-silence.html", "lead_paragraph": "Mr. Shkreli\u2019s new defense lawyer, Benjamin Brafman, said he had advised his client, who faces securities fraud charges, to stop talking to the media and posting on Twitter.", "headline": {"main": "Martin Shkreli Appears to Adopt a New Legal Strategy: Silence", "print_headline": "Accepting Lower Profile, Shkreli Appears in Court"}, "_id": "56b26d2b38f0d82036f0a842", "word_count": "683", "multimedia": [{"height": 126, "url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 440, "url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "440"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/04/business/04shkreli-web2/04shkreli-web2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-02-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Securities and Commodities Violations", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "KaloBios Pharmaceuticals Inc.", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Retrophin Inc", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y", "rank": "6"}, {"name": "persons", "value": "Brafman, Benjamin", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}